Cargando…
IDF21-0295 Cost-effectiveness of telemedicine care for uncontrolled type 2 diabetes mellitus patients during the COVID-19 pandemic
| Autores principales: | , , , , , , |
|---|---|
| Formato: | Online Artículo Texto |
| Lenguaje: | English |
| Publicado: |
Elsevier Scientific Publishers
2022
|
| Materias: | |
| Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9364884/ http://dx.doi.org/10.1016/j.diabres.2022.109334 |
| _version_ | 1784765235596361728 |
|---|---|
| author | Almutairi, M. Bin Rsheed, M.A. Alharbi, J.T. Tourkmani, M.A. Alrasheedy, A.A Alruthia, Y. Aljehani, M. |
| author_facet | Almutairi, M. Bin Rsheed, M.A. Alharbi, J.T. Tourkmani, M.A. Alrasheedy, A.A Alruthia, Y. Aljehani, M. |
| author_sort | Almutairi, M. |
| collection | PubMed |
| description | |
| format | Online Article Text |
| id | pubmed-9364884 |
| institution | National Center for Biotechnology Information |
| language | English |
| publishDate | 2022 |
| publisher | Elsevier Scientific Publishers |
| record_format | MEDLINE/PubMed |
| spelling | pubmed-93648842022-08-10 IDF21-0295 Cost-effectiveness of telemedicine care for uncontrolled type 2 diabetes mellitus patients during the COVID-19 pandemic Almutairi, M. Bin Rsheed, M.A. Alharbi, J.T. Tourkmani, M.A. Alrasheedy, A.A Alruthia, Y. Aljehani, M. Diabetes Res Clin Pract Article Elsevier Scientific Publishers 2022-04 2022-06-03 /pmc/articles/PMC9364884/ http://dx.doi.org/10.1016/j.diabres.2022.109334 Text en Since January 2020 Elsevier has created a COVID-19 resource centre with free information in English and Mandarin on the novel coronavirus COVID-19. The COVID-19 resource centre is hosted on Elsevier Connect, the company's public news and information website. Elsevier hereby grants permission to make all its COVID-19-related research that is available on the COVID-19 resource centre - including this research content - immediately available in PubMed Central and other publicly funded repositories, such as the WHO COVID database with rights for unrestricted research re-use and analyses in any form or by any means with acknowledgement of the original source. These permissions are granted for free by Elsevier for as long as the COVID-19 resource centre remains active. |
| spellingShingle | Article Almutairi, M. Bin Rsheed, M.A. Alharbi, J.T. Tourkmani, M.A. Alrasheedy, A.A Alruthia, Y. Aljehani, M. IDF21-0295 Cost-effectiveness of telemedicine care for uncontrolled type 2 diabetes mellitus patients during the COVID-19 pandemic |
| title | IDF21-0295 Cost-effectiveness of telemedicine care for uncontrolled type 2 diabetes mellitus patients during the COVID-19 pandemic |
| title_full | IDF21-0295 Cost-effectiveness of telemedicine care for uncontrolled type 2 diabetes mellitus patients during the COVID-19 pandemic |
| title_fullStr | IDF21-0295 Cost-effectiveness of telemedicine care for uncontrolled type 2 diabetes mellitus patients during the COVID-19 pandemic |
| title_full_unstemmed | IDF21-0295 Cost-effectiveness of telemedicine care for uncontrolled type 2 diabetes mellitus patients during the COVID-19 pandemic |
| title_short | IDF21-0295 Cost-effectiveness of telemedicine care for uncontrolled type 2 diabetes mellitus patients during the COVID-19 pandemic |
| title_sort | idf21-0295 cost-effectiveness of telemedicine care for uncontrolled type 2 diabetes mellitus patients during the covid-19 pandemic |
| topic | Article |
| url | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9364884/ http://dx.doi.org/10.1016/j.diabres.2022.109334 |
| work_keys_str_mv | AT almutairim idf210295costeffectivenessoftelemedicinecareforuncontrolledtype2diabetesmellituspatientsduringthecovid19pandemic AT binrsheedma idf210295costeffectivenessoftelemedicinecareforuncontrolledtype2diabetesmellituspatientsduringthecovid19pandemic AT alharbijt idf210295costeffectivenessoftelemedicinecareforuncontrolledtype2diabetesmellituspatientsduringthecovid19pandemic AT tourkmanima idf210295costeffectivenessoftelemedicinecareforuncontrolledtype2diabetesmellituspatientsduringthecovid19pandemic AT alrasheedyaa idf210295costeffectivenessoftelemedicinecareforuncontrolledtype2diabetesmellituspatientsduringthecovid19pandemic AT alruthiay idf210295costeffectivenessoftelemedicinecareforuncontrolledtype2diabetesmellituspatientsduringthecovid19pandemic AT aljehanim idf210295costeffectivenessoftelemedicinecareforuncontrolledtype2diabetesmellituspatientsduringthecovid19pandemic |